SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-569610
Filing Date
2016-04-29
Accepted
2016-04-29 16:45:01
Documents
5
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d186882ddefa14a.htm DEFA14A 17365
2 GRAPHIC g186882img001.jpg GRAPHIC 96951
3 GRAPHIC g186882img002.jpg GRAPHIC 142933
4 GRAPHIC g186882img003.jpg GRAPHIC 43898
5 GRAPHIC g186882img004.jpg GRAPHIC 6454
  Complete submission text file 0001193125-16-569610.txt   408166
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32979 | Film No.: 161607480
SIC: 2834 Pharmaceutical Preparations